NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹198 Cr | ₹143 Cr | ₹124 Cr | ₹103 Cr | ₹83 Cr |
What is the latest Total Non-Current Assets ratio of NGL FINECHEM ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2025 | ₹198 Cr |
| Mar2024 | ₹143 Cr |
| Mar2023 | ₹124 Cr |
| Mar2022 | ₹103 Cr |
| Mar2021 | ₹83 Cr |
How is Total Non-Current Assets of NGL FINECHEM Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹198 Cr | 38.60 | |
| Mar2024 | ₹143 Cr | 14.83 | |
| Mar2023 | ₹124 Cr | 20.29 | |
| Mar2022 | ₹103 Cr | 24.83 | |
| Mar2021 | ₹83 Cr | - | |
Compare Total Non-Current Assets of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹1,050.9 Cr | 12.2% | 28.9% | 4.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,341.0 Cr | -2.3% | -7.3% | -12.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,401.0 Cr | 0.8% | -5.8% | 4.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,175.0 Cr | 0.8% | 3.7% | 20.8% | Stock Analytics | |
| CIPLA | ₹107,100.0 Cr | 0.7% | -11.2% | -6.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,715.9 Cr | -1.4% | -3.8% | -1.3% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | 12.2% |
28.9% |
4.4% |
| SENSEX | -1% |
-4.7% |
6% |
You may also like the below Video Courses